Menu
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Diabetes Stock Insulet Dropped 12% in October


Shares of Insulet (NASDAQ: PODD) declined 11.9% in October, according to data from S&P Global Market Intelligence. The S&P 500 returned 2.2% last month.

The Boston-area healthcare company is the leader in tubeless insulin pump technology with its Omnipod pump.

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
Share

Comments